Increased expression of ABCG2 (BCRP) promotes adaptive resistance to niraparib in novel clinically relevant models of treatment resistant ovarian cancer

Activity: Talk or presentation typesInvited talk

Description

Molecular Determinants of Cancer Therapy Resistance - IRB Barcelona BioMed conference
Period18 Nov 202420 Nov 2024
Event titleMolecular Determinants of Cancer Therapy Resistance - IRB BioMed Conference series
Event typeConference
LocationBarcelona, SpainShow on map
Degree of RecognitionInternational